Abbonarsi

Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION) - 07/09/13

Doi : 10.1016/j.ahj.2013.06.002 
Robert J. Mentz, MD a, , Vera Bittner, MD, MSPH b, Phillip J. Schulte, PhD c, Jerome L. Fleg, MD d, Ileana L. Piña, MD, MPH e, Steven J. Keteyian, PhD f, Gordon Moe, MD g, Anil Nigam, MD, MSc h, Ann M. Swank, PhD i, Anekwe E. Onwuanyi, MD j, Meredith Fitz-Gerald, RN, BSN b, Andrew Kao, MD k, Stephen J. Ellis, PhD c, William E. Kraus, MD a, David J. Whellan, MD, MHS l, Christopher M. O'Connor, MD a
a Duke University, Durham, NC 
b University of Alabama at Birmingham, Birmingham, AL 
c DCRI, Durham, NC 
d NHLBI, Bethesda, MD 
e Montefiore-Einstein Medical Center, New York, NY 
f Henry Ford Hospital, Detroit, MI 
g St Michael's Hospital, Toronto, Canada 
h Montreal Heart Institute and University of Montreal, Montreal, Canada 
i University of Louisville, Louisville, KY 
j Morehouse School of Medicine, Atlanta, GA 
k Saint Luke's Mid-America Heart Institute, Kansas City, MO 
l Thomas Jefferson University, Philadelphia, PA 

Reprint requests: Robert J. Mentz, MD, 2301 Erwin Road, Durham, NC 27710.

Riassunto

Background

The strength of race as an independent predictor of long-term outcomes in a contemporary chronic heart failure (HF) population and its association with exercise training response have not been well established. We aimed to investigate the association between race and outcomes and to explore interactions with exercise training in patients with ambulatory HF.

Methods

We performed an analysis of HF-ACTION, which randomized 2331 patients with HF having an ejection fraction ≤35% to usual care with or without exercise training. We examined characteristics and outcomes (mortality/hospitalization, mortality, and cardiovascular mortality/HF hospitalization) by race using adjusted Cox models and explored an interaction with exercise training.

Results

There were 749 self-identified black patients (33%). Blacks were younger with significantly more hypertension and diabetes, less ischemic etiology, and lower socioeconomic status versus whites. Blacks had shorter 6-minute walk distance and lower peak VO2 at baseline. Over a median follow-up of 2.5 years, black race was associated with increased risk for all outcomes except mortality. After multivariable adjustment, black race was associated with increased mortality/hospitalization (hazard ratio [HR] 1.16, 95% CI 1.01-1.33) and cardiovascular mortality/HF hospitalization (HR 1.46, 95% CI 1.20-1.77). The hazard associated with black race was largely caused by increased HF hospitalization (HR 1.58, 95% CI 1.27-1.96), given similar cardiovascular mortality. There was no interaction between race and exercise training on outcomes (P > .5).

Conclusions

Black race in patients with chronic HF was associated with increased prevalence of modifiable risk factors, lower exercise performance, and increased HF hospitalization, but not increased mortality or a differential response to exercise training.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Hector O. Ventura, MD served as guest editor for this article.


© 2013  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 166 - N° 3

P. 488 - settembre 2013 Ritorno al numero
Articolo precedente Articolo precedente
  • Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
  • G.B. John Mancini, Pamela M. Hartigan, Eric R. Bates, Bernard R. Chaitman, Steven P. Sedlis, David J. Maron, William J. Kostuk, John A. Spertus, Koon K. Teo, Marcin Dada, Merril Knudtson, Daniel S. Berman, David C. Booth, William E. Boden, William S. Weintraub
| Articolo seguente Articolo seguente
  • Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
  • Pieter A. Vriesendorp, Arend F.L. Schinkel, Johan Van Cleemput, Rik Willems, Luc J.L.M. Jordaens, Dominic A.M.J. Theuns, Marjon A. van Slegtenhorst, Thomy J. de Ravel, Folkert J. ten Cate, Michelle Michels

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.